Both in Pharmaceuticals
Arcutis Biotherapeutics vs AbCellera Biologics
Over the past year ARQT returned +29.2% and ABCL returned +126.8%; their daily moves had a correlation of 0.27.
ARQT +29.2% ABCL +126.8%Growth of $1, one year, split-adjusted
| Metric | ARQT | ABCL |
|---|---|---|
| Price | $32.00 | $12.18 |
| Market cap | $4.02B | $3.95B |
| Today | +2.37% | +9.53% |
| 1 month | +27.2% | −11.6% |
| 6 months | +36.6% | +161.4% |
| Year to date | +10.2% | +256.1% |
| 1 year | +26.4% | +119.5% |
| Revenue growth (YoY) | +59.3% | −76.3% |
| Gross margin | 91.6% | 100.0% |
| Net margin | 11.6% | −1368.6% |
| P/E (TTM) | 141.0× | — |
| Price / sales | 8.7× | 59.6× |
| Net cash | $129.7M | $540.1M |
| Dividend yield | — | — |
| Volatility (60d) | 53.5% | 78.1% |
| Short % of float | 18.0% | 14.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).